Tejara Capital LTD Cardiol Therapeutics Inc. Transaction History
Tejara Capital LTD
- $275 Billion
- Q2 2024
A detailed history of Tejara Capital LTD transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Tejara Capital LTD holds 1,722,243 shares of CRDL stock, worth $3.39 Million. This represents 1.26% of its overall portfolio holdings.
Number of Shares
1,722,243
Previous 1,644,410
4.73%
Holding current value
$3.39 Million
Previous $2.98 Billion
16.88%
% of portfolio
1.26%
Previous 1.09%
Shares
6 transactions
Others Institutions Holding CRDL
# of Institutions
45Shares Held
5.47MCall Options Held
162KPut Options Held
7.4K-
Advisor Shares Investments LLC Bethesda, MD1.47MShares$2.89 Million0.55% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9924KShares$1.82 Million0.36% of portfolio
-
Lion Street Advisors, LLC253KShares$498,9630.19% of portfolio
-
Cambridge Investment Research Advisors, Inc.116KShares$228,7780.0% of portfolio
-
Knoll Capital Management, LLC Miami, FL100KShares$197,0000.14% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $122M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...